Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03ZAE
|
|||
Former ID |
DIB015523
|
|||
Drug Name |
Peg-G-CSF
|
|||
Synonyms |
Peg-G-CSF (chemotherapy induced side effects)
Click to Show/Hide
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 3 | [1] | |
Company |
Phage Biotechnology Corp
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Granulocyte colony-stimulating factor receptor (G-CSF-R) | Target Info | Stimulator | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
PI3K-Akt signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
Pathways in cancer | ||||
NetPath Pathway | Leptin Signaling Pathway | |||
RANKL Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01674855) Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia. U.S. National Institutes of Health. | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1719). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.